13C mannitol as a novel biomarker for measurement of intestinal permeability

Neurogastroenterology and Motility

Volumn 28, Issue 7, 2016, Pages 1114-1119

  Grover, M ^a   Camilleri, M ^a   Hines, J ^a   Burton, D ^a   Ryks, M ^a   Wadhwa, A ^a   Sundt, W ^a   Dyer, R ^a   Singh, R J ^a  

^a MAYO CLINIC   (United States)

Author keywords

barrier function; gastrointestinal; irritable bowel syndrome; lactulose

Indexed keywords

ISOTOPE; LACTULOSE; MANNITOL; MANNITOL C 13; UNCLASSIFIED DRUG;

ARTICLE; COLON FLORA; COMPARATIVE STUDY; CONTAMINATION; ELECTROSPRAY; FEMALE; GLUCOSE URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINAL EXCRETION; INTESTINE MUCOSA PERMEABILITY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 84977111375     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12802     Document Type: Article

References (11)

1. Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil 2012; 24: 503–12.
2. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108: 1566–81.
3. Kubica P, Kot-Wasik A, Namiesnik J, Namieśnik J, Landowski P. Modern approach for determination of lactulose, mannitol and sucrose in human urine using HPLC-MS/MS for the studies of intestinal and upper digestive tract permeability. J Chromatog B Analyt Technol Biomed Life Sci 2012; 907: 34–40.
4. Smecuol E, Bai JC, Sugai E, Vazquez H, Niveloni S, Pedreira S, Mauriño E, Meddings J. Acute gastrointestinal permability responses to different non-steroidal anti-inflammatory drugs. Gut 2001; 49: 650–5.
5. Sequeira IR, Lentle RG, Kruger MC, Hurst RD. The effect of aspirin and smoking on urinary excretion profiles of lactulose and mannitol in young women: toward a dynamic, aspirin augmented, test of gut mucosal permeability. Neurogastroenterol Motil 2012; 24: e401–11.
6. Kelly CP, Green PH, Murray JA, Dimarino A, Colatrella A, Leffler DA, Alexander T, Arsenescu R et al.; Larazotide Acetate Celiac Disease Study Group. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. Aliment Pharmacol Ther 2013; 37: 252–62.
7. Smith HE, Ryan KN, Stephenson KB, Westcott C, Thakwalakwa C, Maleta K, Cheng JY, Brenna JT et al. Multiple micronutrient supplementation transiently ameliorates environmental enteropathy in Malawian children aged 12-35 months in a randomized controlled clinical trial. J Nutr 2014; 144: 2059–65.
8. Meddings JB, Gibbons I. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology 1998; 114: 83–92.
9. Vocke RD Jr, Schultz L, Bohlke JK, Dietz HJ, Ding TP, Ebihara M, Gramlich JW, Halliday AN et al. IUPAC Subcommittee for isotopic abundance measurements. Pure Appl Chem 1999; 71: 1593–607.
10. Rao AS, Camilleri M, Eckert DJ, Busciglio I, Burton DD, Ryks M, Wong BS, Lamsam J et al. Urine sugars for in vivo gut permability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol Gastrointest Liver Physiol 2011; 301: G919–28.
11. Ortiz ME, Raya RR, Mozzi F. Efficient mannitol production by wild-type Lactobacillus reuteri CRL 1101 is attained at constant pH using a simplified culture medium. Appl Microbiol Biotechnol 2015; 99: 8717–29.